Prospective Database of Factors Associated With Faecal vs. Double Incontinence in Patients Referred for High Resolution Anorectal Manometry.

Sponsor
Universitair Ziekenhuis Brussel (Other)
Overall Status
Recruiting
CT.gov ID
NCT05550675
Collaborator
(none)
150
1
96.8
1.6

Study Details

Study Description

Brief Summary

This study aims to verify the results from our previous retrospective cohort analysis by establishing a database of well-characterised patients prospectively. The different prevalence of neurological disorders, abdominal, urological and obstetrical surgery, diarrhoea and other potential associated factors as well as the importance of abnormalities identified by 3D high resolution anorectal manometry (HARM) will be compared between subjects with feacal incontinence (FI), double incontinence (DI) and controls. Presence and severity of both FI and urinary incontinence (UI) will be evaluated by disease specific questionnaires. Measuring both disease severity and Quality of Life (QoL) is needed to determine the true impact of incontinence. Finally, the impact on quality of life will be compared between both groups.

Condition or Disease Intervention/Treatment Phase
  • Other: Questionnaires

Detailed Description

Double incontinence (DI) is the concomitant incontinence for urine and stool. A 3 - 5 % prevalence among adults has been reported, while 7 - 18 % of community-dwelling adults suffer from faecal incontinence (FI), irrespective of gender. Risk factors for FI include structural anomalies of the anorectal region, disturbed rectal compliance, disturbed anorectal sensation and presence of diarrhoea. Age, body mass index (BMI), obstetrical history (especially parity), anal penetrative intercourse and chronic illness have also been implicated. In contrast, little is known about the pathophysiology of DI. Factors like older age, multiparity, neurological disease and medical comorbidities have been proposed based on analysis from the Nurse's health study. According to our recent retrospective cohort analysis (accepted for publication Acta Gastro-Enterologica Belgica), diarrhoea, neurological disease and previous urological interventions characterise patients suffering from DI. Males most frequently suffer from an underlying neurologic disorder, while anatomical anomalies and urological surgery was more frequently observed in women. There was a trend toward more frequent diarrhoea in both genders. Anorectal manometry parameters could not differentiate between FI alone or DI. However, this result could have been hampered by the use of conventional manometry in contrast to high-resolution 3D manometry.

This study aims to verify the results from our previous retrospective cohort analysis by establishing a database of well-characterised patients prospectively. The different prevalence of neurological disorders, abdominal, urological and obstetrical surgery, diarrhoea and other potential associated factors as well as the importance of abnormalities identified by 3D high resolution anorectal manometry (HARM) will be compared between subjects with FI, DI and controls. Presence and severity of both FI and UI will be evaluated by disease specific questionnaires.

Study Design

Study Type:
Observational
Anticipated Enrollment :
150 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Prospective Database of Factors Associated With Faecal vs. Double Incontinence in Patients Referred for High Resolution Anorectal Manometry.
Actual Study Start Date :
Jun 8, 2022
Anticipated Primary Completion Date :
Jul 1, 2027
Anticipated Study Completion Date :
Jul 1, 2030

Arms and Interventions

Arm Intervention/Treatment
Double incontinence

Other: Questionnaires
Disease specific questionnaires

faecal incontinence

Other: Questionnaires
Disease specific questionnaires

controls

Other: Questionnaires
Disease specific questionnaires

Outcome Measures

Primary Outcome Measures

  1. compose a database of patients suffering from faecal or double incontinence [during inclusion visit]

    a database will be created

Secondary Outcome Measures

  1. Confirm the role of diarrhea as a major determinant of double incontinence vs faecal incontinence [during inclusion visit]

    this outcome will be assessed using jorge and wexner score

  2. Confirm the role of diarrhea as a major determinant of double incontinence vs faecal incontinence [during inclusion visit]

    this outcome will be assessed using vaizey score

  3. Confirm the role of diarrhea as a major determinant of double incontinence vs faecal incontinence [during inclusion visit]

    this outcome will be assessed using International consultation on incontinence questionnaire

  4. Confirm the role of diarrhea as a major determinant of double incontinence vs faecal incontinence [during inclusion visit]

    this outcome will be assessed using clinical frailty score

  5. Confirm the role of diarrhea as a major determinant of double incontinence vs faecal incontinence [during inclusion visit]

    this outcome will be assessed using bristol stool scale

  6. Identify other factors associated with DI vs. FI , [during inclusion visit]

    this outcome will be assessed using bristol stool scale

  7. Identify other factors associated with DI vs. FI , [during inclusion visit]

    this outcome will be assessed using clinical frailty score

  8. Identify other factors associated with DI vs. FI , [during inclusion visit]

    this outcome will be assessed using jorge and wexner score

  9. Identify other factors associated with DI vs. FI , [during inclusion visit]

    this outcome will be assessed using vaizey score

  10. Identify other factors associated with DI vs. FI , [during inclusion visit]

    this outcome will be assessed using International consultation on incontinence questionnaire

  11. Compare manometric data from HARM in DI vs. FI alone; [during inclusion visit]

    this outcome will be assessed using HARM

  12. Assess the prevalence of DI in women and men with FI presenting for HARM; [during inclusion visit]

    this outcome will be assessed using HARM

  13. Investigate the impact of UI on the quality of life in DI vs. FI alone. [during inclusion visit]

    this outcome will be assessed using the Quality of Life questionnaire (faecal incontinence Quality of Life scale)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Age > 18 years;

  • Self-reported faecal incontinence.

Exclusion Criteria:
  • Impossibility to perform the anorectal manometry because of pain, stenosis or organic disease;

  • Active (peri)rectal inflammation, including abscess;

  • Pregnancy;

  • Inability to cooperate during the anorectal manometry

  • Impossibility to perform HARM due to pain, stenosis or organic disease;

  • Inability to complete the questionnaires

Contacts and Locations

Locations

Site City State Country Postal Code
1 UZ Brussel Brussels Belgium 1090

Sponsors and Collaborators

  • Universitair Ziekenhuis Brussel

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Universitair Ziekenhuis Brussel
ClinicalTrials.gov Identifier:
NCT05550675
Other Study ID Numbers:
  • ProDIM
First Posted:
Sep 22, 2022
Last Update Posted:
Sep 22, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 22, 2022